OMIA group 31
Coat colour, dilution, MLPH-related
The chain reaches the human disease Griscelli syndrome type 3, which Mondo defines as: “A Griscelli syndrome characterized by isolated silvery gray sheen of the hair and hypopigmentation of the skin that has material basis in mutation in the MLPH or MYO5A genes.”
The chain
From the animal disease to the drugs. The page shows what each step found and where the chain stopped. It does not say whether the animal is a model of a human disease.
-
Animal disease
Reached
OMIA records it in 1 species entry marked as a defect.
-
Human disease
Reached
1 Mondo disease.
-
Human gene
Reached
1 human gene.
-
Target evidence
Reached
1 Open Targets association, with a best score of 0.69.
-
Drugs
Stopped here
No ChEMBL drug acts on a human gene of the group's target evidence.
The chain stopped at Drugs: No ChEMBL drug acts on a human gene of the group's target evidence.
Natural-model score
How complete and how well supported the chain to each human disease is, out of 100, by stated rules. It does not say that the animal is a validated model of the human disease. How the score works.
58.2 out of 100
| Part | Computed from | Points |
|---|---|---|
| Target evidence | Open Targets score of 0.69 | 24.2 of 35 |
| Drugs | No drug has been tested for this disease, and none acts on its genes | 0.0 of 25 |
| Ortholog | One to one ortholog | 20.0 of 20 |
| Both routes | Both routes found this disease | 10.0 of 10 |
| Species | 1 naturally occurring species entry marked as a defect | 4.0 of 10 |
Species
The chain follows only the species entries that OMIA marks as a defect.
| Species | Scientific name | OMIA entry | A defect |
|---|---|---|---|
| American mink | Neogale vison | OMIA:000031-452646 | No, not counted |
| dog | Canis lupus familiaris | OMIA:000031-9615 | Yes |
| domestic cat | Felis catus | OMIA:000031-9685 | No, not counted |
| domestic cattle | Bos taurus | OMIA:000031-9913 | No, not counted |
| domestic ferret | Mustela putorius furo | OMIA:000031-9669 | No, not counted |
| rabbit | Oryctolagus cuniculus | OMIA:000031-9986 | No, not counted |
| sheep | Ovis aries | OMIA:000031-9940 | No, not counted |
Genes
Each gene OMIA records for a species entry, and the human gene it reaches through Ensembl's orthologs.
| Species | Animal gene | Human gene | Ortholog |
|---|---|---|---|
| dog | MLPH melanophilin NCBI Gene 607077 | MLPH Ensembl | one to one |
| American mink Not a defect, not counted | MLPH NCBI Gene 122902450 | Ensembl does not know this NCBI Gene identifier. | |
| domestic cat Not a defect, not counted | MLPH melanophilin NCBI Gene 780791 | MLPH Ensembl | one to one |
| domestic cattle Not a defect, not counted | MLPH melanophilin NCBI Gene 531343 | MLPH Ensembl | one to one |
| domestic ferret Not a defect, not counted | MLPH melanophilin NCBI Gene 101679226 | MLPH Ensembl | one to one |
| rabbit Not a defect, not counted | MLPH melanophilin NCBI Gene 100343360 | Ensembl does not know this NCBI Gene identifier. | |
| sheep Not a defect, not counted | MLPH melanophilin NCBI Gene 100272215 | MLPH Ensembl | one to one |
Human diseases
Two routes lead from an OMIA group to a Mondo human disease: OMIA's own Mondo link, and the group's OMIM numbers through Mondo's cross-references.
- OMIA's own Mondo link: found a disease.
- OMIA's OMIM numbers: found a disease.
| Mondo disease | Name | Found by |
|---|---|---|
| MONDO:0012220 | Griscelli syndrome type 3 A Griscelli syndrome characterized by isolated silvery gray sheen of the hair and hypopigmentation of the skin that has material basis in mutation in the MLPH or MYO5A genes. | Both routes |
Target evidence
Each Open Targets association between one of the group's human genes and one of its human diseases, with its overall score and the score for each kind of evidence.
| Human gene | Human disease | Score | Evidence | Kinds of evidence |
|---|---|---|---|---|
| MLPH | Griscelli syndrome type 3 | 0.69 | 45 | Genetic association 0.79 Genetic literature 0.57 Animal model 0.46 Literature 0.05 |
Drugs
No ChEMBL drug acts on a human gene of the group's target evidence.